KIEV. Dec 29 – The non-participation of Ukrainian pharmaceutical manufacturers in public procurement of medicines via international organizations due to the absence of the WHO prequalification could have seriously damaged the reputation of Ukrainian manufacturers and they would have had to actively protect their reputation, President of the Association Manufactures of Medications of Ukraine (AMMU) Petro Bahriy told Interfax-Ukraine.

He said that the share of Ukrainian medicines of public procurement today is no more than 30%, although Ukrainian manufacturers are working to boost their market share.